GERN
Geron Corporation
NASDAQ · Healthcare · Biotechnology · US
$1.57
+3.97%Margins
Gross margin
83.2%
EBITDA margin
-20.4%
EBIT margin
-18.3%
Net margin
-34.2%
FCF margin
-56.1%
-32.0%
Return on equity
-13.5%
Return on assets
-11.0%
Return on invested capital
0.39x
Asset turnover
-$114.4M
Cash from operations
$0.47
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026